Abbott Laboratories Share Price
Equities
ABT
US0028241000
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 100.30 USD | -2.36% |
|
-2.50% | -19.95% |
| 04-10 | S&P 500 Posts Weekly Gain Ahead of Iran Peace Talks, Earnings | MT |
| 04-10 | Abbott Ordered to Pay $53 Million in Damages to Chicago Families Over Infant Formula | MT |
| Capitalization | 175B 149B 138B 130B 242B 16,254B 247B 1,620B 632B 7,801B 656B 642B 27,818B | P/E ratio 2026 * |
24.6x | P/E ratio 2027 * | 21.4x |
|---|---|---|---|---|---|
| Enterprise value | 198B 169B 156B 147B 274B 18,447B 281B 1,839B 717B 8,854B 744B 728B 31,571B | EV / Sales 2026 * |
3.92x | EV / Sales 2027 * | 3.52x |
| Free-Float |
86.65% | Yield 2026 * |
2.51% | Yield 2027 * | 2.66% |
Last Transcript: Abbott Laboratories
| 1 day | -2.36% | ||
| 1 week | -2.50% | ||
| Current month | -2.31% | ||
| 1 month | -9.27% | ||
| 3 months | -20.35% | ||
| 6 months | -24.34% | ||
| Current year | -19.95% |
| 1 week | 99.34 | 103.84 | |
| 1 month | 99.34 | 111.86 | |
| Current year | 99.34 | 129.46 | |
| 1 year | 99.34 | 139.06 | |
| 3 years | 89.67 | 141.23 | |
| 5 years | 89.67 | 142.6 | |
| 10 years | 36.76 | 142.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Ford
CEO | Chief Executive Officer | 52 | 30/03/2020 |
Philip Boudreau
DFI | Director of Finance/CFO | 53 | 31/08/2023 |
Sabina Ewing
CIO | Chief Investment Officer | 51 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Alpern
BRD | Director/Board Member | 75 | 09/10/2008 |
Sally Blount
BRD | Director/Board Member | 64 | 08/12/2011 |
Nancy McKinstry
BRD | Director/Board Member | 67 | 08/12/2011 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.36% | -2.50% | -19.44% | -3.28% | 175B | ||
| -0.80% | +0.67% | +5.66% | +8.69% | 112B | ||
| -0.51% | -1.23% | +14.93% | +92.82% | 62.41B | ||
| +1.74% | +6.94% | +89.04% | +108.41% | 62.17B | ||
| -0.80% | -0.19% | -22.55% | -39.17% | 43.91B | ||
| -0.20% | +2.98% | - | - | 37.01B | ||
| -2.53% | +2.89% | -4.87% | -43.11% | 24.64B | ||
| -0.52% | +1.77% | +2.51% | +15.78% | 21.83B | ||
| -1.47% | -1.97% | -25.20% | +15.90% | 19.83B | ||
| +0.83% | +0.71% | +8.51% | -40.87% | 19.45B | ||
| Average | -0.66% | +1.37% | +5.40% | +12.80% | 57.79B | |
| Weighted average by Cap. | -0.96% | +1.23% | +4.28% | +18.52% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 50.61B 43.18B 39.9B 37.61B 70.04B 4,709B 71.69B 469B 183B 2,260B 190B 186B 8,060B | 55.43B 47.29B 43.7B 41.19B 76.7B 5,157B 78.51B 514B 201B 2,475B 208B 204B 8,827B |
| Net income | 7.09B 6.05B 5.59B 5.27B 9.81B 660B 10.04B 65.77B 25.66B 317B 26.61B 26.04B 1,129B | 8.19B 6.99B 6.46B 6.08B 11.33B 762B 11.6B 75.95B 29.63B 366B 30.73B 30.07B 1,304B |
| Net Debt | 23.56B 20.1B 18.58B 17.51B 32.61B 2,193B 33.38B 219B 85.28B 1,052B 88.43B 86.54B 3,753B | 20.26B 17.28B 15.97B 15.05B 28.03B 1,885B 28.69B 188B 73.31B 905B 76.02B 74.4B 3,226B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/04/26 | 100.30 $ | -2.36% | 11,944,755 |
| 09/04/26 | 102.72 $ | -0.81% | 6,198,999 |
| 08/04/26 | 103.56 $ | +1.70% | 9,379,259 |
| 07/04/26 | 101.83 $ | -0.46% | 13,310,997 |
| 06/04/26 | 102.30 $ | -0.55% | 7,125,767 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ABT Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition

















